- This 26-week pilot randomized trial enrolled 35 outpatients with opioid-treated chronic low back pain (21 intervention, 14 control).
- The intervention added eight weekly group sessions combining meditation and CLBP-specific CBT, plus daily at-home practice, to usual care, compared with usual care alone.
- Pain severity fell more in the meditation-CBT group (P = 0.045), with a 1-point between-group difference at 26 weeks (95% CI 0.2 to 1.9; Cohen's d = 0.86), and thermal pain sensitivity also decreased (P < 0.05).
- The authors conclude the intervention reduced pain severity and thermal pain sensitivity without adverse events, and exploratory analyses linked greater meditation practice to larger benefit.
Chronic pain
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Reliability study of 13 older adults (mean age 69.3 ± 8.2 years) with chronic low back pain, using lumbar T1-weighted MRI.
- Two examiners traced muscle regions of interest on the same images to measure relative cross-sectional area and fat infiltration indices, which were then used to calculate relative muscle area.
- Intra-examiner ICCs were 0.77-0.99 for multifidi and erector spinae at L2-L5, and 0.81-0.99 for psoas and quadratus lumborum at L3. Inter-examiner ICCs ranged from poor to excellent.
- The authors conclude that one examiner can measure these indices reliably, and that a substantial share of muscle area may be MRI-visible intramuscular fat.
- This Part IV article uses a modified Delphi consensus process with a principal investigator, a three-member content expert panel, and a nine-member primary care panel.
- It presents an evaluation and treatment algorithm with stepped-care drug recommendations for depression in older adults with chronic low back pain, designed around VHA-available resources.
- The abstract reports no effectiveness data, effect sizes, or p values; its only clinical illustration is a single case.
- The authors conclude that depression is common and should be routinely evaluated in older adults with chronic low back pain so targeted treatment can be planned.
- This observational cohort study followed 493 people with HIV across 6 US sites, all free of distal neuropathic pain at entry.
- Pain was assessed with a standardized clinician-administered instrument at semiannual visits, and predictors were evaluated with mixed-effects logistic regression.
- Twenty-seven percent (131 of 493) developed new distal neuropathic pain over a median follow-up of 24 months; older age, female sex, antiretroviral treatment, and lack of viral suppression predicted onset.
- Lifetime opioid use disorder predicted onset, and more severe depressive symptoms during follow-up were also linked to higher risk, which the authors connect to neuropsychiatric influences.
- Prospective cohort analysis of 699 women with chronic pelvic pain, drawn from a larger study of women with noncancerous pelvic problems who were seeking care.
- The exposure was use of complementary health approaches, compared against sociodemographic, clinical, quality-of-life, attitudinal, and conventional care characteristics.
- Baseline use in the past year was 51%, led by vitamins and minerals (29%) and herbs (27%); 44.8% used them at over half of annual assessments.
- Users were more likely to have had hysterectomy or oophorectomy or to have used GnRH agonists or opioids, and reported higher PPIQ scores (31.6 vs 25.6, P<0.001).
- Clinical review of 92 studies from MEDLINE and Cochrane (January 1990 to May 2014) on persistent pain management in older adults.
- Of the 92 studies, 35 evaluated pharmacologic interventions and 57 examined nonpharmacologic modalities, most often in older adults with osteoarthritis (n = 50).
- The review proposes a stepwise approach with acetaminophen first-line, then topical NSAID, tramadol, or both, and advises against long-term oral NSAIDs.
- The authors strongly recommend a multimodal plan combining medication, rehabilitation, and cognitive-behavioral or movement-based care, built on a strong patient-physician alliance.
- Validation study of 157 chronic pain patients on long-term opioid therapy, followed for 6 months.
- A 12-item Opioid Compliance Checklist was repeatedly administered, and items were checked against aberrant drug-related behavior from urine toxicology, two questionnaires, and staff ratings.
- Five items best predicted later aberrant behavior by multivariate logistic regression, with a cross-validated AUC of 0.67.
- The authors describe the checklist as easy to use and promising for monitoring opioid adherence, but say further testing is needed.
- Preclinical study in awake rats with either post-incisional pain (1 day) or spinal nerve ligation neuropathic pain (14 days), measuring nucleus accumbens shell dopamine by microdialysis.
- Clinically used drugs were tested, including spinal clonidine, gabapentin, ketorolac and naproxen, with sham-operated animals included as controls.
- Gabapentin raised accumbens dopamine only in neuropathic rats, while ketorolac and naproxen did so only in incisional rats, and clonidine raised it dose-dependently in neuropathic rats. No effect sizes or p values are given in the abstract.
- The authors propose accumbens dopamine efflux as an objective neurochemical biomarker of analgesic efficacy for novel mechanisms, with drug responses tracking clinical efficacy patterns.
- Retrospective longitudinal observational cohort of 1,394 patients with 3,488 encounters at an academic inner-city pain clinic in Newark, NJ, from 2006 to 2009.
- A marginal logistic regression with generalized estimating equations assessed which demographic and clinical factors were associated with arriving for scheduled appointments.
- Spanish as primary language and living 5–10 miles away were linked to lower odds of attending; unemployment, interventional procedures, and continuity of care were linked to higher odds.
- The authors conclude that Spanish-language use and distance predicted missed appointments, and that these possible barriers may be modifiable by low-cost interventions.
- Preclinical study using ND7/104 cells, isolated mouse dorsal root ganglion neurons, and rat hind paw mechanical testing; sample sizes are not given in the abstract.
- Endothelin-1 pre-exposure was compared with controls, with BQ-123, 2-APB, TNP-ATP, and 5-BDBD used as receptor and pathway antagonists.
- ET-1 increased the proportion of neurons responding to ATP, and this sensitization depended on extracellular calcium and was blocked by BQ-123, but not by 2-APB.
- TNP-ATP and the P2X4-selective antagonist 5-BDBD inhibited ET-1-induced mechanical sensitization in vivo, suggesting P2X4 sensitization contributes, though the authors call this 'possibly' due to P2X4.
- Preclinical study in Sprague-Dawley rats with spared nerve injury, each implanted with an epidural spinal cord stimulation lead.
- Compared 6-hour versus 30-minute stimulation duration and 50%, 75%, or 90% motor threshold intensity, with sham stimulation as the control.
- Six-hour stimulation significantly raised mechanical withdrawal threshold versus 30-minute or sham stimulation, and 90% motor threshold outperformed the lower intensities; the abstract reports no CIs or p values.
- Both 4 Hz and 60 Hz stimulation reduced dorsal horn glial markers (GFAP, MCP-1, OX-42) versus sham, which the authors suggest may be one mechanism.
- Cross-sectional analysis of 1,903 HIV-infected patients from a prospective cohort at the University of Alabama at Birmingham, using patient-reported pain and function measures.
- Pain was the exposure of interest, modeled against impairment in mobility, self-care, and usual activities while adjusting for mood disorders, substance abuse, and other covariates.
- Pain was independently associated with impairment in mobility (aOR 10.5, 95% CI 7.6-14.6), self-care (aOR 4.1, 95% CI 2.2-7.4), and usual activities (aOR 5.4, 95% CI 4.0-7.4).
- The authors conclude that pain should be an important consideration in HIV primary care and that interventions targeting pain and physical function should be investigated.
- Prospective cohort of 144 adolescents with mild to severe traumatic brain injury, followed for 36 months with repeated pain, mood, and quality-of-life assessments.
- Exposure was the injury itself; the study looked at risk factors for persistent pain rather than comparing an intervention against a control.
- 24.3% reported persistent pain (usual intensity ≥3/10) at all assessment points; female sex (OR 2.73, 95% CI 1.12-6.63) and depressive symptoms at 3 months (OR 1.26, 95% CI 1.12-1.43) predicted pain at 36 months.
- Early pain at 3 months was associated with significantly poorer long-term health-related quality of life, and the authors suggest timely evaluation and intervention may help.
- In 291 healthy adults from three racial and ethnic groups, researchers tested heat, cold, pressure, and ischemic pain plus temporal summation and completed psychological and health questionnaires.
- Principal component analysis of the pain measures produced Pain Sensitivity Index scores, which were then grouped by cluster analysis to find sensitivity patterns across modalities.
- Five clusters emerged, differing by sex, somatic reactivity, and catastrophizing, with the largest differences between heat-sensitive and cold-insensitive individuals. The abstract reports no effect sizes or p values.
- The authors argue that phenotyping accounts for interindividual variability in pain responses and that these profiles were not explained solely by demographic, psychosocial, or health factors.
- This is a narrative review of psychosocial approaches to pain management in older adults, beginning with the biopsychosocial model of pain.
- It highlights three interventions: cognitive behavioural therapy, emotional disclosure, and mind-body approaches (mindfulness-based stress reduction and yoga).
- The abstract reports no pooled outcomes or effect sizes, and it closes by outlining future directions for research in this area.
- Cochrane systematic review and meta-analysis of 23 randomized trials comparing regional with conventional analgesia for persistent postoperative pain at 6 or 12 months.
- Three trials with 250 participants after thoracotomy compared epidural anaesthesia with conventional analgesia at 6 months.
- Epidural anaesthesia was associated with lower odds of persistent pain (OR 0.33, 95% CI 0.20-0.56).
- Paravertebral block for breast cancer surgery, from two studies with 89 participants, also favoured the block (OR 0.37, 95% CI 0.14-0.94), though the authors note small numbers and bias weaken these conclusions.
- Cross-sectional survey of 12,426 workers in 47 occupational groups, mostly nurses and office workers, across 18 countries.
- Compared 1-month prevalence of disabling low back and wrist/hand pain among groups doing similar physical tasks, and tested risk factors with Poisson regression.
- Nurses' disabling low back pain ranged from 9.6% to 42.6%, and office workers' disabling wrist/hand pain from 2.2% to 31.6%, with an up-to 8-fold difference remaining after adjustment.
- The authors conclude that international variation is only partly explained by personal and socioeconomic risk factors, and compensation and incapacity-benefit systems appeared to have little influence on symptoms.
- This cross-sectional analysis of 12,410 adults aged 20-59 from 47 occupational groups in 18 countries used data from the CUPID study.
- Past-month pain at 10 anatomical sites was examined against risk factors using Poisson regression, reported as prevalence rate ratios.
- Extensive pain at 6-10 sites occurred in 674 participants versus 41.9 expected if sites were independent, with stronger risk factor associations than pain at 1-3 sites (e.g., somatising tendency PRR 4.6 vs 1.3).
- After adjusting for the number of painful sites, risk factors showed no added association with ACR-defined widespread pain, and the authors support classifying multisite pain by site count.
- Skin biopsies from the proximal thigh and distal leg compared normal subjects, type 2 diabetics without neuropathy, and diabetic neuropathy patients with or without pain.
- Immunohistochemistry quantified total intraepidermal nerve fibers (PGP9.5) and regenerating fibers (GAP43), with axonal swellings also counted per fiber.
- Painful neuropathy showed higher GAP43/PGP ratios than painless neuropathy in both sites, and more axonal swellings per fiber in the distal leg.
- The swellings stained positive for TrkA and substance P, and the authors suggest these ratios may help separate painful from painless diabetic neuropathy.
- Phase II, randomized, double-blind, placebo-controlled, four-period crossover multicenter trial in patients with at least moderate painful HIV-associated polyneuropathy, with 15 enrolled across eight sites.
- Compared duloxetine, methadone, their combination, and placebo, with the primary outcome being mean pain intensity recorded in a daily pain diary.
- No statistically significant change in mean pain intensity versus placebo was found, and only eight patients completed the trial amid frequent adverse events and discontinuations.
- The authors attribute the limited efficacy evaluation to recruitment and retention problems and emphasize the lessons learned for future trials.
- Comparison of 453 low back pain patients on high-dose opioids with 4,815 on lower-dose opioids and 10,184 on no opioids in primary care.
- Higher-dose was defined as at least 100 mg/day morphine equivalent at last dispensing, with 90 or more consecutive days of opioids, versus lower-dose or no opioids.
- High-dose use occurred in 2.9% of opioid recipients and 8.6% of long-term recipients, with a median of 180.0 mg/day; co-prescribed sedative-hypnotics had an adjusted OR of 1.75 (95% CI 1.42-2.16).
- Higher-dose patients had more mental health and substance use disorders, more emergency and pain clinic visits, and the authors flag potential safety concerns.
- Retrospective confirmatory factor analysis of 184 men with castrate-resistant prostate cancer whose Brief Pain Inventory was collected in CALGB trial 9480.
- The authors compared a one-factor model with two- and three-factor models built from the instrument's design, which split interference into affective and activity domains.
- The three-factor model (pain intensity, activity interference, affective interference) fit best, with RMSEA 0.075, CFI 0.971, and a chi-square change of 13.33 (P < 0.05).
- The authors conclude the BPI can separately quantify affective and activity interference, and that the three-factor structure was invariant across age, PSA, and hemoglobin levels.
- Case-control study of 76 TMD patients with widespread palpation tenderness, 83 TMD patients without it, and 181 matched non-TMD controls.
- The exposure was widespread body palpation tenderness, and the outcome was the number of comorbid pain conditions and related pain and psychological measures.
- TMD patients averaged 1.7 comorbid pain conditions versus 0.3 in controls (P < .001), with an OR of 8.4 (95% CI 3.1-22.8) for TMD with tenderness.
- Patients with tenderness had lower pressure pain thresholds in cranial and extracranial sites and more somatic symptoms, and the authors suggest body-wide pain assessment in TMD.
- Cross-sectional genetic study of 247 healthy young adults from three ethnic groups (81 African American, 79 non-white Hispanic, 87 non-Hispanic white) undergoing multiple experimental pain tests.
- Pain sensitivity was compared across OPRM1 A118G genotypes (presence of the minor G allele versus consensus alleles), analyzed separately within each ethnic group.
- Across the whole sample, genotype did not significantly affect pain sensitivity, but significant genotype effects appeared for most modalities in non-Hispanic whites (P<.05), not in Hispanics or African Americans.
- The authors conclude that the OPRM1 association with pain sensitivity depends on ethnicity, and they suggest haplotype differences or linked functional variants as possible explanations.
- Preclinical study in rats with spinal nerve ligation, testing whether PKMζ-dependent and independent amplification contribute to neuropathic pain components.
- Intra-rACC ZIP (a PKMζ inhibitor) was compared with MK-801 (an NMDA blocker) for aversiveness, and spinal ZIP or MK-801 was tested for evoked hypersensitivity.
- rACC ZIP reversed the injury-induced aversive state within 24 hours, with full recovery by 7 days, while MK-801 had no effect on aversiveness.
- Spinal ZIP or MK-801 transiently reversed evoked hypersensitivity but did not affect spontaneous pain, suggesting different amplification mechanisms at different levels of the neuraxis.
- This fMRI study of 60 healthy participants used psychophysiological interaction analysis to compare how low and high experimental pain changed periaqueductal gray connectivity in men and women.
- Connectivity was compared between exposure to low-intensity and high-intensity experimental pain.
- Pain thresholds did not differ by sex, and in both sexes PAG connectivity with somatosensory cortex, supplementary motor area, cerebellum and thalamus increased during high pain.
- Only 26 men, not women, showed a pain-induced rise in PAG connectivity with amygdala, caudate and putamen, hinting at sex-specific endogenous pain inhibition.
- Cross-sectional analysis of 106 patients with rheumatoid arthritis, using baseline data from a prospective self-management study.
- Assessed disease activity, pain, helplessness, pain coping, depression, and self-reported sleep disturbance using validated questionnaires.
- Hierarchical regression found higher income, pain, internality, and depression each contributed independently to greater sleep disturbance; no effect sizes are reported in the abstract.
- Mediation analysis suggested depression is a significant pathway through which pain contributes to sleep disturbance, and the authors propose targeting pain and depression to improve sleep.
- Case-control study of 344 females, measuring blood levels of 22 cytokines and activity of 48 transcription factors in people with temporomandibular disorder (TMD).
- Compared TMD with and without widespread palpation tenderness (WPT), and linked the biomarkers to genotypes, quantitative sensory testing, and questionnaire measures.
- TMD-WPT cases had higher MCP-1 and IL-1ra, TMD+WPT cases had higher IL-8, and TGFβ1 transcription activity was inhibited in both groups.
- A TGFβ1 rs2241719 minor allele interacted with IL-8 rs4073 genotype, with odds of TMD+WPT reported as about twice or half, depending on genotype; authors propose these markers as potential diagnostic and therapeutic targets.
- Cross-sectional analysis of 652 community-dwelling older adults with symptomatic knee and/or hip osteoarthritis, drawn from the Health, Aging, and Body Composition Study (year 6, 2002-03).
- Examined prevalence and correlates of non-opioid and opioid analgesic use, with doses standardized to each agent's minimum effective daily dose.
- Severe or extreme OA pain was associated with both non-opioid (AOR 2.44, 95% CI 1.49-3.99) and opioid use (AOR 2.64, 95% CI 1.26-5.53).
- Of the 19.3% with inadequate pain control, 39% took less than one standardized daily dose, which the authors suggest may reflect undertreatment.
- Structural equation modeling of 921 HIV-seropositive and 1019 HIV-seronegative gay/bisexual men in the prospective MACS cohort, using six years of repeated measures.
- Pain was the central variable, linking sociodemographics, HIV status and CD4 count to depressive symptoms and illicit drug use.
- Pain predicted more cannabis, cocaine and heroin use and more depressive symptoms, and the path models were similar by HIV status; no effect sizes are reported.
- HIV-seropositive status predicted more inhaled nitrite use, and lower CD4 counts, African American race, less education and older age were linked to more pain. The authors call for better pain management in vulnerable subgroups.
- This secondary analysis of a randomized controlled trial included 147 adults with opioid dependence and depressive symptoms who were starting buprenorphine/naloxone.
- Participants were randomized to escitalopram 10 mg daily or placebo, and pain severity and interference were tracked over 3 months with panel regression.
- Escitalopram was associated with larger reductions in pain severity (b=-14.34, t=-2.66, P<.01) and pain interference (b=-1.20, t=-2.23, P<.05) than placebo.
- Adjusting for within-person changes in depression left the pain effects virtually unchanged, and the authors describe the reductions as clinically meaningful.
- Retrospective review of VA administrative data from ambulatory clinics in one regional network, covering 762 OEF/OIF veterans with chronic noncancer pain and repeated elevated pain screens in 2008.
- Compared veterans prescribed opioids (n=485) with those not prescribed (n=277), and short-term (<90 days, n=284) with long-term (≥90 consecutive days, n=201) opioid users.
- Sixty-four percent received at least one opioid, and 41% of those were long-term users; mean morphine-equivalent dose was 23.7 mg for short-term versus 40.8 mg for long-term users (P < 0.001).
- Low back pain, migraine, PTSD, and nicotine use disorder were associated with higher likelihood of an opioid prescription after adjustment, and half of long-term users received only short-acting opioids.
- This expert panel report summarizes an NIH Pain Consortium conference held in September 2010, where 18 panelists presented and joined multidisciplinary discussions.
- Meeting transcripts and slide presentations were reviewed to identify research gaps and the study methods panelists proposed to address them in older adults.
- Fifteen gaps were identified across treatment, epidemiology, and implementation, with a specific focus on opioids and NSAIDs because their risks and benefits remain uncertain.
- Panelists proposed electronic health databases, observational cohorts, and ongoing cohorts with pain outcomes as practical ways to build an age-appropriate evidence base.
- Observational comparison of adults with chronic low back and radicular pain against matched healthy controls, using arterial spin labeling across three sessions.
- Clinical maneuvers were used to worsen ongoing pain, and noxious heat matched to that pain intensity was applied to the affected leg dermatome.
- Worsening of ongoing pain (n = 16) was linked to regional blood flow increases of 6-10 mL/100 g/min (P < 0.01) in somatosensory, prefrontal, insular, and superior parietal regions.
- The authors found the increases were specific to worsening ongoing pain, absent with thermal pain or in controls, and present the technique as a step toward objective pain biomarkers.
- Study of 54 youth with functional abdominal pain and 53 healthy controls, aged 10 to 16, using a visual probe detection task.
- Participants completed the task before and after random assignment to failure or success feedback on a challenging computer game, with trait anxiety controlled.
- At conscious presentation, FAP patients attended preferentially to pain words compared with neutral words and with controls, and this persisted after feedback in both conditions.
- Preconscious attention was neutral at baseline in FAP patients but shifted toward pain after feedback in both conditions, suggesting performance evaluation may activate it.
- Pharmacokinetic study of 21 subjects with sickle cell disease, examined during steady-state health rather than during painful episodes.
- A single morphine sulfate infusion at 0.1 mg/kg, with plasma morphine and metabolite levels measured over time and compared with published non-SCD estimates.
- Morphine clearance was 2.4-3.6 L/h and half-life 0.3-0.7 h, with clearance reported as 3-10 fold higher than non-SCD estimates.
- The authors suggest faster clearance may explain higher morphine requirements, possibly from increased hepatic and renal blood flow, and favor individualized dosing.
- Veterans in one VA regional network with chronic non-cancer pain were compared across high-dose (n=478), traditional-dose (n=500), and no-opioid (n=500) groups.
- High-dose was defined as at least 180 mg/day morphine equivalent for 90 or more consecutive days.
- High-dose use occurred in 2.4% of chronic pain patients and 8.2% of long-term opioid patients; black veterans were less likely to receive high doses (p=0.03).
- After adjustment, neuropathy, low back pain, and nicotine dependence were associated with increased likelihood of high-dose prescriptions.
- Analysis of a randomized trial comparing collaborative care with usual care in 362 primary care patients with chronic noncancer pain, 72 of whom had a substance use disorder history.
- The exposure was a history of substance use disorder, and the outcome was a 30% or greater reduction in Roland Morris Disability Questionnaire score at 12 months.
- Within the usual care group, SUD history was associated with lower odds of clinically significant improvement (OR 0.30, 95% CI 0.11-0.82), while the model was not significant in the collaborative care group.
- Patients with SUD had poorer baseline function and higher rates of major depression and PTSD, and the authors conclude SUD status did not impede improvement with collaborative care.
- Prospective cohort of 155 pediatric functional abdominal pain patients and 45 well controls, followed up to 15 years, with telephone interviews at ages 18 to 32.
- Patients were grouped as Resolved (n=101) or Unresolved (n=54) at follow-up using adult Rome III functional GI criteria; the Unresolved group was the exposure of interest.
- Chronic non-abdominal pain was reported by 48.1% of Unresolved, 24.7% of Resolved, and 13.3% of controls (p<0.01); headache by 57.4%, 44.6%, and 31% (p<0.05).
- Persistent FAP into adulthood may increase risk for chronic pain and headache, and about one-third of the Unresolved group reported both.
- Mouse study comparing TRPM8-null, TRPM8/TRPA1 double-knockout, and TRPA1-null mice to determine which channel mediates acute cold pain responses.
- Behavioral tests of warm-cold preference, surface avoidance, and icilin nocifension were paired with c-fos expression after hindpaw noxious cold, menthol, or icilin.
- TRPM8-deficient and double-knockout mice lost cold avoidance and icilin nocifensive responses and showed reduced c-fos, while TRPA1-null mice retained them.
- The authors conclude that noxious cold signaling depends on TRPM8 and that TRPA1 is not required for acute cold pain in mammals.